High Tech Pharm Co. Ltd Asset Resilience Ratio
High Tech Pharm Co. Ltd asset resilience ratio. High Tech Pharm Co. Ltd (106190) has an Asset Resilience Ratio of 0.77% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See High Tech Pharm Co. Ltd (106190) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of High Tech Pharm Co. Ltd (2014–2024)
Asset resilience ratio of High Tech Pharm Co. Ltd from 2014 to 2024. This chart shows how High Tech Pharm Co. Ltd's Asset Resilience Ratio has changed over time. Read debt load of High Tech Pharm Co. Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down High Tech Pharm Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 106190 asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.07 Billion | 0.77% |
| Total Liquid Assets | ₩1.07 Billion | 0.77% |
Asset Resilience Insights
- Limited Liquidity: High Tech Pharm Co. Ltd maintains only 0.77% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
High Tech Pharm Co. Ltd Industry Peers by Asset Resilience Ratio
Compare High Tech Pharm Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
High Tech Pharm Co. Ltd Asset Resilience Ratio by Year (2014–2024)
High Tech Pharm Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for High Tech Pharm Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.00% | ₩450.00 ≈ $0.30 |
₩140.09 Billion ≈ $94.94 Million |
-1.39pp |
| 2023-12-31 | 1.39% | ₩1.88 Billion ≈ $1.28 Million |
₩135.06 Billion ≈ $91.53 Million |
-4.56pp |
| 2022-12-31 | 5.96% | ₩7.87 Billion ≈ $5.34 Million |
₩132.20 Billion ≈ $89.59 Million |
-4.32pp |
| 2021-12-31 | 10.28% | ₩12.63 Billion ≈ $8.56 Million |
₩122.94 Billion ≈ $83.31 Million |
+9.47pp |
| 2020-12-31 | 0.80% | ₩1.03 Billion ≈ $699.90K |
₩128.45 Billion ≈ $87.05 Million |
-7.04pp |
| 2019-12-31 | 7.84% | ₩10.33 Billion ≈ $7.00 Million |
₩131.73 Billion ≈ $89.27 Million |
+4.86pp |
| 2018-12-31 | 2.98% | ₩3.96 Billion ≈ $2.68 Million |
₩133.00 Billion ≈ $90.13 Million |
+0.46pp |
| 2017-12-31 | 2.52% | ₩3.00 Billion ≈ $2.03 Million |
₩119.10 Billion ≈ $80.71 Million |
-5.99pp |
| 2016-12-31 | 8.51% | ₩10.06 Billion ≈ $6.82 Million |
₩118.31 Billion ≈ $80.18 Million |
-0.40pp |
| 2015-12-31 | 8.91% | ₩9.92 Billion ≈ $6.72 Million |
₩111.43 Billion ≈ $75.51 Million |
-12.24pp |
| 2014-12-31 | 21.14% | ₩22.53 Billion ≈ $15.27 Million |
₩106.60 Billion ≈ $72.24 Million |
-- |
About High Tech Pharm Co. Ltd
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.